Get the Stockscreener App
26.80
0.85%
-0.23
After Hours:
26.80
Enovis Corp stock is traded at $26.80, with a volume of 1.38M.
It is down -0.85% in the last 24 hours and down -14.54% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$27.03
Open:
$26.72
24h Volume:
1.38M
Relative Volume:
0.97
Market Cap:
$1.53B
Revenue:
$2.15B
Net Income/Loss:
$-809.46M
P/E Ratio:
-1.9211
EPS:
-13.95
Net Cash Flow:
$-38.98M
1W Performance:
-1.33%
1M Performance:
-14.54%
6M Performance:
-42.95%
1Y Performance:
-43.74%
1-Day Range:
$26.21
$27.13
1-Week Range:
$26.21
$28.09
52-Week Range:
$25.93
$49.83
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
26.80 | 1.54B | 2.15B | -809.46M | -38.98M | -13.95 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
What is Enovis Corporation company’s growth strategyMarket Forecast Recommendation With Low Risk - jammulinksnews.com
Sectors Driving Future Growth for Enovis Corporation StockTriple Digit Growth Focused Trade Plan Reviewed - metal.it
Enovis Corporation: Five-Year Profitability Woes and Share Price Down 70% - AInvest
The past five years for Enovis (NYSE:ENOV) investors has not been profitable - Yahoo Finance
Why Enovis Corporation stock attracts strong analyst attentionAI Screening for Swing Trade Picks Finds Momentum - metal.it
RSI and MACD Indicate Shift in Enovis Corporation SentimentBreakout Momentum Picks With Protection Outlined - metal.it
What is the risk reward ratio of investing in Enovis Corporation stockHigh-performance investment picks - jammulinksnews.com
What are analysts’ price targets for Enovis Corporation in the next 12 monthsBuild a winning investment strategy - jammulinksnews.com
How does Enovis Corporation generate profit in a changing economyRobust investment performance - jammulinksnews.com
Does Enovis Corporation stock perform well during market downturnsInvest confidently with professional market insights - jammulinksnews.com
Is Enovis Corporation a growth stock or a value stockAccelerated profit realization - jammulinksnews.com
What are the latest earnings results for Enovis CorporationIdentify undervalued stocks ready to soar - jammulinksnews.com
What institutions are buying Enovis Corporation stock now5x Profit Potential - metal.it
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
What analysts say about Enovis Corporation stockLightning-fast capital gains - Autocar Professional
What analysts say about Enovis Corporation stock outlookHigh-performance investment picks - jammulinksnews.com
What drives Enovis Corporation stock priceFree Trading Psychology Coaching - Autocar Professional
Is Enovis Corporation a good long term investmentHigh-yield growth strategies - PrintWeekIndia
Enovis Corporation Stock Analysis and ForecastFree Real-Time Stock Data - PrintWeekIndia
Enovis (NYSE:ENOV Shareholders Incur Further Losses as Stock Declines 12% This Week, Taking Five-year Losses to 48% - 富途牛牛
Published on: 2025-07-23 01:36:14 - jammulinksnews.com
Enovis Corporation (NYSE:ENOV) Stock Rises Amid Market OptimismNews and Statistics - IndexBox
Enovis Corporation's (NYSE:ENOV) Shares Lagging The Industry But So Is The Business - simplywall.st
Enovis (ENOV) Stock Trades Up, Here Is Why - TradingView
Enovis Shares Plunge 14.81% Amid Accounting Concerns - AInvest
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Enovis stock hits 52-week low at 28.81 USD - Investing.com
Enovis stock hits 52-week low at 28.81 USD By Investing.com - Investing.com Canada
Enovis stock ticks down after Jehoshaphat Research reveals short position By Investing.com - Investing.com India
Enovis stock ticks down after Jehoshaphat Research reveals short position - Investing.com
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):